866-997-4948(US-Canada Toll Free)

Europe Antibacterial Drug Resistance Market Report 2017

Published By :

QYResearch

Published Date : Feb 2017

Category :

Pharmaceutical

No. of Pages : 125 Pages

Notes:
Sales, means the sales volume of Antibacterial Drug Resistance
Revenue, means the sales value of Antibacterial Drug Resistance

This report studies sales (consumption) of Antibacterial Drug Resistance in Europe market, especially in Germany, France, UK, Russia, Italy, Spain and Benelux, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering
AAIPharma Services
ANTABIO
Abgentis
Abbott Laboratories
Absynth Biologics
Achaogen
Acino Holdings
Aventis Pharma
Austell Laboratories
Assembly Biosciences
Arpida
Demuris
Evolva Holding
ContraFect
Cerexa
GSK
InterMune
Isis Pharmaceuticals
Lyndra
Microbecide
Morphochem
Nabriva Therapeutics
NanoSafe Coatings
Novexel
Osel
PENDOPHARM
Pfizer
VenatoRx Pharmaceuticals

Market Segment by Countries, this report splits Europe into several key Countries, with sales (consumption), revenue, market share and growth rate of Antibacterial Drug Resistance in these countries, from 2011 to 2021 (forecast), like
Germany
France
UK
Russia
Italy
Spain
Benelux

Split by product type, with sales, revenue, price, market share and growth rate of each type, can be divided into
Telavancin (Vibativ?)
Ceftaroline Fosamil (Teflaro? / Zinforo)
Fidaxomicin (Dificid / Dificlir?)
Ceftobiprole Medocaril (Zevtera? / Zeftera? / Mabelio?)
Dalbavancin (Dalvance? / Xydalba?)
Tedizolid Phosphate (Sivextro?)
Oritavancin (Orbactiv? / Nuvocid?)
Ceftolozane-Tazobactam (Zerbaxa?)
Ceftazidime-Avibactam (Avycaz? / Zavicefta)
PHASE III DRUGS

Split by application, this report focuses on sales, market share and growth rate of Antibacterial Drug Resistance in each application, can be divided into
Gram-Positive
Gram-Negative

Table of Contents

Europe Antibacterial Drug Resistance Market Report 2017
1 Antibacterial Drug Resistance Overview
1.1 Product Overview and Scope of Antibacterial Drug Resistance
1.2 Classification of Antibacterial Drug Resistance
1.2.1 Telavancin (Vibativ?)
1.2.2 Ceftaroline Fosamil (Teflaro? / Zinforo)
1.2.3 Fidaxomicin (Dificid / Dificlir?)
1.2.4 Ceftobiprole Medocaril (Zevtera? / Zeftera? / Mabelio?)
1.2.5 Dalbavancin (Dalvance? / Xydalba?)
1.2.6 Tedizolid Phosphate (Sivextro?)
1.2.7 Oritavancin (Orbactiv? / Nuvocid?)
1.2.8 Ceftolozane-Tazobactam (Zerbaxa?)
1.2.9 Ceftazidime-Avibactam (Avycaz? / Zavicefta)
1.2.10 PHASE III DRUGS
1.3 Application of Antibacterial Drug Resistance
1.3.1 Gram-Positive
1.3.2 Gram-Negative
1.4 Antibacterial Drug Resistance Market by Countries
1.4.1 Germany Status and Prospect (2012-2022)
1.4.2 France Status and Prospect (2012-2022)
1.4.3 UK Status and Prospect (2012-2022)
1.4.4 Russia Status and Prospect (2012-2022)
1.4.5 Italy Status and Prospect (2012-2022)
1.4.6 Spain Status and Prospect (2012-2022)
1.4.7 Benelux Status and Prospect (2012-2022)
1.5 Europe Market Size (Value and Volume) of Antibacterial Drug Resistance (2012-2022)
1.5.1 Europe Antibacterial Drug Resistance Sales and Growth Rate (2012-2022)
1.5.2 Europe Antibacterial Drug Resistance Revenue and Growth Rate (2012-2022)

2 Europe Antibacterial Drug Resistance by Manufacturers, Type and Application
2.1 Europe Antibacterial Drug Resistance Market Competition by Manufacturers
2.1.1 Europe Antibacterial Drug Resistance Sales and Market Share of Key Manufacturers (2015 and 2016)
2.1.2 Europe Antibacterial Drug Resistance Revenue and Share by Manufacturers (2015 and 2016)
2.2 Europe Antibacterial Drug Resistance (Volume and Value) by Type
2.2.1 Europe Antibacterial Drug Resistance Sales and Market Share by Type (2012-2017)
2.2.2 Europe Antibacterial Drug Resistance Revenue and Market Share by Type (2012-2017)
2.3 Europe Antibacterial Drug Resistance (Volume and Value) by Countries
2.3.1 Europe Antibacterial Drug Resistance Sales and Market Share by Countries (2012-2017)
2.3.2 Europe Antibacterial Drug Resistance Revenue and Market Share by Countries (2012-2017)
2.4 Europe Antibacterial Drug Resistance (Volume) by Application

3 Germany Antibacterial Drug Resistance (Volume, Value and Sales Price)
3.1 Germany Antibacterial Drug Resistance Sales and Value (2012-2017)
3.1.1 Germany Antibacterial Drug Resistance Sales and Growth Rate (2012-2017)
3.1.2 Germany Antibacterial Drug Resistance Revenue and Growth Rate (2012-2017)
3.1.3 Germany Antibacterial Drug Resistance Sales Price Trend (2012-2017)
3.2 Germany Antibacterial Drug Resistance Sales and Market Share by Manufacturers
3.3 Germany Antibacterial Drug Resistance Sales and Market Share by Type
3.4 Germany Antibacterial Drug Resistance Sales and Market Share by Application

4 France Antibacterial Drug Resistance (Volume, Value and Sales Price)
4.1 France Antibacterial Drug Resistance Sales and Value (2012-2017)
4.1.1 France Antibacterial Drug Resistance Sales and Growth Rate (2012-2017)
4.1.2 France Antibacterial Drug Resistance Revenue and Growth Rate (2012-2017)
4.1.4 France Antibacterial Drug Resistance Sales Price Trend (2012-2017)
4.2 France Antibacterial Drug Resistance Sales and Market Share by Manufacturers
4.3 France Antibacterial Drug Resistance Sales and Market Share by Type
4.4 France Antibacterial Drug Resistance Sales and Market Share by Application

5 UK Antibacterial Drug Resistance (Volume, Value and Sales Price)
5.1 UK Antibacterial Drug Resistance Sales and Value (2012-2017)
5.1.1 UK Antibacterial Drug Resistance Sales and Growth Rate (2012-2017)
5.1.2 UK Antibacterial Drug Resistance Revenue and Growth Rate (2012-2017)
5.1.5 UK Antibacterial Drug Resistance Sales Price Trend (2012-2017)
5.2 UK Antibacterial Drug Resistance Sales and Market Share by Manufacturers
5.3 UK Antibacterial Drug Resistance Sales and Market Share by Type
5.4 UK Antibacterial Drug Resistance Sales and Market Share by Application

6 Russia Antibacterial Drug Resistance (Volume, Value and Sales Price)
6.1 Russia Antibacterial Drug Resistance Sales and Value (2012-2017)
6.1.1 Russia Antibacterial Drug Resistance Sales and Growth Rate (2012-2017)
6.1.2 Russia Antibacterial Drug Resistance Revenue and Growth Rate (2012-2017)
6.1.6 Russia Antibacterial Drug Resistance Sales Price Trend (2012-2017)
6.2 Russia Antibacterial Drug Resistance Sales and Market Share by Manufacturers
6.3 Russia Antibacterial Drug Resistance Sales and Market Share by Type
6.4 Russia Antibacterial Drug Resistance Sales and Market Share by Application

7 Italy Antibacterial Drug Resistance (Volume, Value and Sales Price)
7.1 Italy Antibacterial Drug Resistance Sales and Value (2012-2017)
7.1.1 Italy Antibacterial Drug Resistance Sales and Growth Rate (2012-2017)
7.1.2 Italy Antibacterial Drug Resistance Revenue and Growth Rate (2012-2017)
7.1.7 Italy Antibacterial Drug Resistance Sales Price Trend (2012-2017)
7.2 Italy Antibacterial Drug Resistance Sales and Market Share by Manufacturers
7.3 Italy Antibacterial Drug Resistance Sales and Market Share by Type
7.4 Italy Antibacterial Drug Resistance Sales and Market Share by Application

8 Spain Antibacterial Drug Resistance (Volume, Value and Sales Price)
8.1 Spain Antibacterial Drug Resistance Sales and Value (2012-2017)
8.1.1 Spain Antibacterial Drug Resistance Sales and Growth Rate (2012-2017)
8.1.2 Spain Antibacterial Drug Resistance Revenue and Growth Rate (2012-2017)
8.1.8 Spain Antibacterial Drug Resistance Sales Price Trend (2012-2017)
8.2 Spain Antibacterial Drug Resistance Sales and Market Share by Manufacturers
8.3 Spain Antibacterial Drug Resistance Sales and Market Share by Type
8.4 Spain Antibacterial Drug Resistance Sales and Market Share by Application

9 Benelux Antibacterial Drug Resistance (Volume, Value and Sales Price)
9.1 Benelux Antibacterial Drug Resistance Sales and Value (2012-2017)
9.1.1 Benelux Antibacterial Drug Resistance Sales and Growth Rate (2012-2017)
9.1.2 Benelux Antibacterial Drug Resistance Revenue and Growth Rate (2012-2017)
9.1.9 Benelux Antibacterial Drug Resistance Sales Price Trend (2012-2017)
9.2 Benelux Antibacterial Drug Resistance Sales and Market Share by Manufacturers
9.3 Benelux Antibacterial Drug Resistance Sales and Market Share by Type
9.4 Benelux Antibacterial Drug Resistance Sales and Market Share by Application

10 Europe Antibacterial Drug Resistance Manufacturers Analysis
10.1 AAIPharma Services
10.1.1 Company Basic Information, Manufacturing Base and Competitors
10.1.2 Antibacterial Drug Resistance Product Type, Application and Specification
10.1.2.1 Telavancin (Vibativ?)
10.1.2.2 Ceftaroline Fosamil (Teflaro? / Zinforo)
10.1.3 AAIPharma Services Antibacterial Drug Resistance Sales, Revenue, Price and Gross Margin (2012-2017)
10.1.4 Main Business/Business Overview
10.2 ANTABIO
10.2.1 Company Basic Information, Manufacturing Base and Competitors
10.2.2 Antibacterial Drug Resistance Product Type, Application and Specification
10.2.2.1 Telavancin (Vibativ?)
10.2.2.2 Ceftaroline Fosamil (Teflaro? / Zinforo)
10.2.3 ANTABIO Antibacterial Drug Resistance Sales, Revenue, Price and Gross Margin (2012-2017)
10.2.4 Main Business/Business Overview
10.3 Abgentis
10.3.1 Company Basic Information, Manufacturing Base and Competitors
10.3.2 Antibacterial Drug Resistance Product Type, Application and Specification
10.3.2.1 Telavancin (Vibativ?)
10.3.2.2 Ceftaroline Fosamil (Teflaro? / Zinforo)
10.3.3 Abgentis Antibacterial Drug Resistance Sales, Revenue, Price and Gross Margin (2012-2017)
10.3.4 Main Business/Business Overview
10.4 Abbott Laboratories
10.4.1 Company Basic Information, Manufacturing Base and Competitors
10.4.2 Antibacterial Drug Resistance Product Type, Application and Specification
10.4.2.1 Telavancin (Vibativ?)
10.4.2.2 Ceftaroline Fosamil (Teflaro? / Zinforo)
10.4.3 Abbott Laboratories Antibacterial Drug Resistance Sales, Revenue, Price and Gross Margin (2012-2017)
10.4.4 Main Business/Business Overview
10.5 Absynth Biologics
10.5.1 Company Basic Information, Manufacturing Base and Competitors
10.5.2 Antibacterial Drug Resistance Product Type, Application and Specification
10.5.2.1 Telavancin (Vibativ?)
10.5.2.2 Ceftaroline Fosamil (Teflaro? / Zinforo)
10.5.3 Absynth Biologics Antibacterial Drug Resistance Sales, Revenue, Price and Gross Margin (2012-2017)
10.5.4 Main Business/Business Overview
10.6 Achaogen
10.6.1 Company Basic Information, Manufacturing Base and Competitors
10.6.2 Antibacterial Drug Resistance Product Type, Application and Specification
10.6.2.1 Telavancin (Vibativ?)
10.6.2.2 Ceftaroline Fosamil (Teflaro? / Zinforo)
10.6.3 Achaogen Antibacterial Drug Resistance Sales, Revenue, Price and Gross Margin (2012-2017)
10.6.4 Main Business/Business Overview
10.7 Acino Holdings
10.7.1 Company Basic Information, Manufacturing Base and Competitors
10.7.2 Antibacterial Drug Resistance Product Type, Application and Specification
10.7.2.1 Telavancin (Vibativ?)
10.7.2.2 Ceftaroline Fosamil (Teflaro? / Zinforo)
10.7.3 Acino Holdings Antibacterial Drug Resistance Sales, Revenue, Price and Gross Margin (2012-2017)
10.7.4 Main Business/Business Overview
10.8 Aventis Pharma
10.8.1 Company Basic Information, Manufacturing Base and Competitors
10.8.2 Antibacterial Drug Resistance Product Type, Application and Specification
10.8.2.1 Telavancin (Vibativ?)
10.8.2.2 Ceftaroline Fosamil (Teflaro? / Zinforo)
10.8.3 Aventis Pharma Antibacterial Drug Resistance Sales, Revenue, Price and Gross Margin (2012-2017)
10.8.4 Main Business/Business Overview
10.9 Austell Laboratories
10.9.1 Company Basic Information, Manufacturing Base and Competitors
10.9.2 Antibacterial Drug Resistance Product Type, Application and Specification
10.9.2.1 Telavancin (Vibativ?)
10.9.2.2 Ceftaroline Fosamil (Teflaro? / Zinforo)
10.9.3 Austell Laboratories Antibacterial Drug Resistance Sales, Revenue, Price and Gross Margin (2012-2017)
10.9.4 Main Business/Business Overview
10.10 Assembly Biosciences
10.10.1 Company Basic Information, Manufacturing Base and Competitors
10.10.2 Antibacterial Drug Resistance Product Type, Application and Specification
10.10.2.1 Telavancin (Vibativ?)
10.10.2.2 Ceftaroline Fosamil (Teflaro? / Zinforo)
10.10.3 Assembly Biosciences Antibacterial Drug Resistance Sales, Revenue, Price and Gross Margin (2012-2017)
10.10.4 Main Business/Business Overview
10.11 Arpida
10.12 Demuris
10.13 Evolva Holding
10.14 ContraFect
10.15 Cerexa
10.16 GSK
10.17 InterMune
10.18 Isis Pharmaceuticals
10.19 Lyndra
10.20 Microbecide
10.21 Morphochem
10.22 Nabriva Therapeutics
10.23 NanoSafe Coatings
10.24 Novexel
10.25 Osel
10.26 PENDOPHARM
10.27 Pfizer
10.28 VenatoRx Pharmaceuticals

11 Antibacterial Drug Resistance Manufacturing Cost Analysis
11.1 Antibacterial Drug Resistance Key Raw Materials Analysis
11.1.1 Key Raw Materials
11.1.2 Price Trend of Key Raw Materials
11.1.3 Key Suppliers of Raw Materials
11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Antibacterial Drug Resistance

12 Industrial Chain, Sourcing Strategy and Downstream Buyers
12.1 Antibacterial Drug Resistance Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Antibacterial Drug Resistance Major Manufacturers in 2015
12.4 Downstream Buyers

13 Marketing Strategy Analysis, Distributors/Traders
13.1 Marketing Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
13.2.1 Pricing Strategy
13.2.2 Brand Strategy
13.2.3 Target Client
13.3 Distributors/Traders List

14 Europe Antibacterial Drug Resistance Market Forecast (2017-2022)
14.1 Germany Antibacterial Drug Resistance Sales Forecast (2017-2022)
14.2 France Antibacterial Drug Resistance Sales Forecast (2017-2022)
14.3 UK Antibacterial Drug Resistance Sales Forecast (2017-2022)
14.4 Russia Antibacterial Drug Resistance Sales Forecast (2017-2022)
14.5 Italy Antibacterial Drug Resistance Sales Forecast (2017-2022)
14.6 Spain Antibacterial Drug Resistance Sales Forecast (2017-2022)
14.7 Benelux Antibacterial Drug Resistance Sales Forecast (2017-2022)
14.8 Europe Antibacterial Drug Resistance Sales Forecast by Type (2017-2022)
14.9 Europe Antibacterial Drug Resistance Sales Forecast by Application (2017-2022)

15 Research Findings and Conclusion

16 Appendix
Methodology
Analyst Introduction
Data Source


List of Table

List of Tables and Figures

Figure Picture of Antibacterial Drug Resistance
Table Classification of Antibacterial Drug Resistance
Figure Europe Sales Market Share of Antibacterial Drug Resistance by Type in 2015
Figure Telavancin (Vibativ?) Picture
Figure Ceftaroline Fosamil (Teflaro? / Zinforo) Picture
Figure Fidaxomicin (Dificid / Dificlir?) Picture
Figure Ceftobiprole Medocaril (Zevtera? / Zeftera? / Mabelio?) Picture
Figure Dalbavancin (Dalvance? / Xydalba?) Picture
Figure Tedizolid Phosphate (Sivextro?) Picture
Figure Oritavancin (Orbactiv? / Nuvocid?) Picture
Figure Ceftolozane-Tazobactam (Zerbaxa?) Picture
Figure Ceftazidime-Avibactam (Avycaz? / Zavicefta) Picture
Figure PHASE III DRUGS Picture
Table Application of Antibacterial Drug Resistance
Figure Europe Sales Market Share of Antibacterial Drug Resistance by Application in 2015
Figure Gram-Positive Examples
Figure Gram-Negative Examples
Figure Germany Antibacterial Drug Resistance Revenue and Growth Rate (2012-2022)
Figure France Antibacterial Drug Resistance Revenue and Growth Rate (2012-2022)
Figure UK Antibacterial Drug Resistance Revenue and Growth Rate (2012-2022)
Figure Russia Antibacterial Drug Resistance Revenue and Growth Rate (2012-2022)
Figure Italy Antibacterial Drug Resistance Revenue and Growth Rate (2012-2022)
Figure Spain Antibacterial Drug Resistance Revenue and Growth Rate (2012-2022)
Figure Benelux Antibacterial Drug Resistance Revenue and Growth Rate (2012-2022)
Figure Europe Antibacterial Drug Resistance Sales and Growth Rate (2012-2022)
Figure Europe Antibacterial Drug Resistance Revenue and Growth Rate (2012-2022)
Table Europe Antibacterial Drug Resistance Sales of Key Manufacturers (2015 and 2016)
Table Europe Antibacterial Drug Resistance Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Antibacterial Drug Resistance Sales Share by Manufacturers
Figure 2016 Antibacterial Drug Resistance Sales Share by Manufacturers
Table Europe Antibacterial Drug Resistance Revenue by Manufacturers (2015 and 2016)
Table Europe Antibacterial Drug Resistance Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Europe Antibacterial Drug Resistance Revenue Share by Manufacturers
Table 2016 Europe Antibacterial Drug Resistance Revenue Share by Manufacturers
Table Europe Antibacterial Drug Resistance Sales and Market Share by Type (2012-2017)
Table Europe Antibacterial Drug Resistance Sales Share by Type (2012-2017)
Figure Sales Market Share of Antibacterial Drug Resistance by Type (2012-2017)
Figure Europe Antibacterial Drug Resistance Sales Growth Rate by Type (2012-2017)
Table Europe Antibacterial Drug Resistance Revenue and Market Share by Type (2012-2017)
Table Europe Antibacterial Drug Resistance Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Antibacterial Drug Resistance by Type (2012-2017)
Figure Europe Antibacterial Drug Resistance Revenue Growth Rate by Type (2012-2017)
Table Europe Antibacterial Drug Resistance Sales and Market Share by Countries (2012-2017)
Table Europe Antibacterial Drug Resistance Sales Share by Countries (2012-2017)
Figure Sales Market Share of Antibacterial Drug Resistance by Countries (2012-2017)
Table Europe Antibacterial Drug Resistance Revenue and Market Share by Countries (2012-2017)
Table Europe Antibacterial Drug Resistance Revenue Share by Countries (2012-2017)
Figure Revenue Market Share of Antibacterial Drug Resistance by Countries (2012-2017)
Table Europe Antibacterial Drug Resistance Sales and Market Share by Application (2012-2017)
Table Europe Antibacterial Drug Resistance Sales Share by Application (2012-2017)
Figure Sales Market Share of Antibacterial Drug Resistance by Application (2012-2017)
Figure Germany Antibacterial Drug Resistance Sales and Growth Rate (2012-2017)
Figure Germany Antibacterial Drug Resistance Revenue and Growth Rate (2012-2017)
Figure Germany Antibacterial Drug Resistance Sales Price Trend (2012-2017)
Table Germany Antibacterial Drug Resistance Sales by Manufacturers (2015 and 2016)
Table Germany Antibacterial Drug Resistance Market Share by Manufacturers (2015 and 2016)
Table Germany Antibacterial Drug Resistance Sales by Type (2015 and 2016)
Table Germany Antibacterial Drug Resistance Market Share by Type (2015 and 2016)
Table Germany Antibacterial Drug Resistance Sales by Application (2015 and 2016)
Table Germany Antibacterial Drug Resistance Market Share by Application (2015 and 2016)
Figure France Antibacterial Drug Resistance Sales and Growth Rate (2012-2017)
Figure France Antibacterial Drug Resistance Revenue and Growth Rate (2012-2017)
Figure France Antibacterial Drug Resistance Sales Price Trend (2012-2017)
Table France Antibacterial Drug Resistance Sales by Manufacturers (2015 and 2016)
Table France Antibacterial Drug Resistance Market Share by Manufacturers (2015 and 2016)
Table France Antibacterial Drug Resistance Sales by Type (2015 and 2016)
Table France Antibacterial Drug Resistance Market Share by Type (2015 and 2016)
Table France Antibacterial Drug Resistance Sales by Application (2015 and 2016)
Table France Antibacterial Drug Resistance Market Share by Application (2015 and 2016)
Figure UK Antibacterial Drug Resistance Sales and Growth Rate (2012-2017)
Figure UK Antibacterial Drug Resistance Revenue and Growth Rate (2012-2017)
Figure UK Antibacterial Drug Resistance Sales Price Trend (2012-2017)
Table UK Antibacterial Drug Resistance Sales by Manufacturers (2015 and 2016)
Table UK Antibacterial Drug Resistance Market Share by Manufacturers (2015 and 2016)
Table UK Antibacterial Drug Resistance Sales by Type (2015 and 2016)
Table UK Antibacterial Drug Resistance Market Share by Type (2015 and 2016)
Table UK Antibacterial Drug Resistance Sales by Application (2015 and 2016)
Table UK Antibacterial Drug Resistance Market Share by Application (2015 and 2016)
Figure Russia Antibacterial Drug Resistance Sales and Growth Rate (2012-2017)
Figure Russia Antibacterial Drug Resistance Revenue and Growth Rate (2012-2017)
Figure Russia Antibacterial Drug Resistance Sales Price Trend (2012-2017)
Table Russia Antibacterial Drug Resistance Sales by Manufacturers (2015 and 2016)
Table Russia Antibacterial Drug Resistance Market Share by Manufacturers (2015 and 2016)
Table Russia Antibacterial Drug Resistance Sales by Type (2015 and 2016)
Table Russia Antibacterial Drug Resistance Market Share by Type (2015 and 2016)
Table Russia Antibacterial Drug Resistance Sales by Application (2015 and 2016)
Table Russia Antibacterial Drug Resistance Market Share by Application (2015 and 2016)
Figure Italy Antibacterial Drug Resistance Sales and Growth Rate (2012-2017)
Figure Italy Antibacterial Drug Resistance Revenue and Growth Rate (2012-2017)
Figure Italy Antibacterial Drug Resistance Sales Price Trend (2012-2017)
Table Italy Antibacterial Drug Resistance Sales by Manufacturers (2015 and 2016)
Table Italy Antibacterial Drug Resistance Market Share by Manufacturers (2015 and 2016)
Table Italy Antibacterial Drug Resistance Sales by Type (2015 and 2016)
Table Italy Antibacterial Drug Resistance Market Share by Type (2015 and 2016)
Table Italy Antibacterial Drug Resistance Sales by Application (2015 and 2016)
Table Italy Antibacterial Drug Resistance Market Share by Application (2015 and 2016)
Figure Spain Antibacterial Drug Resistance Sales and Growth Rate (2012-2017)
Figure Spain Antibacterial Drug Resistance Revenue and Growth Rate (2012-2017)
Figure Spain Antibacterial Drug Resistance Sales Price Trend (2012-2017)
Table Spain Antibacterial Drug Resistance Sales by Manufacturers (2015 and 2016)
Table Spain Antibacterial Drug Resistance Market Share by Manufacturers (2015 and 2016)
Table Spain Antibacterial Drug Resistance Sales by Type (2015 and 2016)
Table Spain Antibacterial Drug Resistance Market Share by Type (2015 and 2016)
Table Spain Antibacterial Drug Resistance Sales by Application (2015 and 2016)
Table Spain Antibacterial Drug Resistance Market Share by Application (2015 and 2016)
Figure Benelux Antibacterial Drug Resistance Sales and Growth Rate (2012-2017)
Figure Benelux Antibacterial Drug Resistance Revenue and Growth Rate (2012-2017)
Figure Benelux Antibacterial Drug Resistance Sales Price Trend (2012-2017)
Table Benelux Antibacterial Drug Resistance Sales by Manufacturers (2015 and 2016)
Table Benelux Antibacterial Drug Resistance Market Share by Manufacturers (2015 and 2016)
Table Benelux Antibacterial Drug Resistance Sales by Type (2015 and 2016)
Table Benelux Antibacterial Drug Resistance Market Share by Type (2015 and 2016)
Table Benelux Antibacterial Drug Resistance Sales by Application (2015 and 2016)
Table Benelux Antibacterial Drug Resistance Market Share by Application (2015 and 2016)
Table Antibacterial Drug Resistance Basic Information List
Table AAIPharma Services Antibacterial Drug Resistance Sales, Revenue, Price and Gross Margin (2012-2017)
Figure AAIPharma Services Antibacterial Drug Resistance Sales Market Share (2012-2017)
Table ANTABIO Basic Information List
Table ANTABIO Antibacterial Drug Resistance Sales, Revenue, Price and Gross Margin (2012-2017)
Table ANTABIO Antibacterial Drug Resistance Sales Market Share (2012-2017)
Table Abgentis Basic Information List
Table Abgentis Antibacterial Drug Resistance Sales, Revenue, Price and Gross Margin (2012-2017)
Table Abgentis Antibacterial Drug Resistance Sales Market Share (2012-2017)
Table Abbott Laboratories Basic Information List
Table Abbott Laboratories Antibacterial Drug Resistance Sales, Revenue, Price and Gross Margin (2012-2017)
Table Abbott Laboratories Antibacterial Drug Resistance Sales Market Share (2012-2017)
Table Absynth Biologics Basic Information List
Table Absynth Biologics Antibacterial Drug Resistance Sales, Revenue, Price and Gross Margin (2012-2017)
Table Absynth Biologics Antibacterial Drug Resistance Sales Market Share (2012-2017)
Table Achaogen Basic Information List
Table Achaogen Antibacterial Drug Resistance Sales, Revenue, Price and Gross Margin (2012-2017)
Table Achaogen Antibacterial Drug Resistance Sales Market Share (2012-2017)
Table Acino Holdings Basic Information List
Table Acino Holdings Antibacterial Drug Resistance Sales, Revenue, Price and Gross Margin (2012-2017)
Table Acino Holdings Antibacterial Drug Resistance Sales Market Share (2012-2017)
Table Aventis Pharma Basic Information List
Table Aventis Pharma Antibacterial Drug Resistance Sales, Revenue, Price and Gross Margin (2012-2017)
Table Aventis Pharma Antibacterial Drug Resistance Sales Market Share (2012-2017)
Table Austell Laboratories Basic Information List
Table Austell Laboratories Antibacterial Drug Resistance Sales, Revenue, Price and Gross Margin (2012-2017)
Table Austell Laboratories Antibacterial Drug Resistance Sales Market Share (2012-2017)
Table Assembly Biosciences Basic Information List
Table Assembly Biosciences Antibacterial Drug Resistance Sales, Revenue, Price and Gross Margin (2012-2017)
Table Assembly Biosciences Antibacterial Drug Resistance Sales Market Share (2012-2017)
Table Arpida Basic Information List
Table Demuris Basic Information List
Table Evolva Holding Basic Information List
Table ContraFect Basic Information List
Table Cerexa Basic Information List
Table GSK Basic Information List
Table InterMune Basic Information List
Table Isis Pharmaceuticals Basic Information List
Table Lyndra Basic Information List
Table Microbecide Basic Information List
Table Morphochem Basic Information List
Table Nabriva Therapeutics Basic Information List
Table NanoSafe Coatings Basic Information List
Table Novexel Basic Information List
Table Osel Basic Information List
Table PENDOPHARM Basic Information List
Table Pfizer Basic Information List
Table VenatoRx Pharmaceuticals Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Antibacterial Drug Resistance
Figure Manufacturing Process Analysis of Antibacterial Drug Resistance
Figure Antibacterial Drug Resistance Industrial Chain Analysis
Table Raw Materials Sources of Antibacterial Drug Resistance Major Manufacturers in 2015
Table Major Buyers of Antibacterial Drug Resistance
Table Distributors/Traders List
Figure Germany Antibacterial Drug Resistance Sales and Growth Rate Forecast (2017-2022)
Figure Germany Antibacterial Drug Resistance Revenue and Growth Rate Forecast (2017-2022)
Figure France Antibacterial Drug Resistance Sales and Growth Rate Forecast (2017-2022)
Figure France Antibacterial Drug Resistance Revenue and Growth Rate Forecast (2017-2022)
Figure UK Antibacterial Drug Resistance Sales and Growth Rate Forecast (2017-2022)
Figure UK Antibacterial Drug Resistance Revenue and Growth Rate Forecast (2017-2022)
Figure Russia Antibacterial Drug Resistance Sales and Growth Rate Forecast (2017-2022)
Figure Russia Antibacterial Drug Resistance Revenue and Growth Rate Forecast (2017-2022)
Figure Italy Antibacterial Drug Resistance Sales and Growth Rate Forecast (2017-2022)
Figure Italy Antibacterial Drug Resistance Revenue and Growth Rate Forecast (2017-2022)
Figure Spain Antibacterial Drug Resistance Sales and Growth Rate Forecast (2017-2022)
Figure Spain Antibacterial Drug Resistance Revenue and Growth Rate Forecast (2017-2022)
Figure Benelux Antibacterial Drug Resistance Sales and Growth Rate Forecast (2017-2022)
Figure Benelux Antibacterial Drug Resistance Revenue and Growth Rate Forecast (2017-2022)
Table Europe Antibacterial Drug Resistance Sales Forecast by Type (2017-2022)
Table Europe Antibacterial Drug Resistance Sales Forecast by Application (2017-2022)

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *